Web Analytics

Knapp Kits for Visual Inspection

Schedule a Meeting

Knapp Kits forVisual Inspection

A Knapp Kit is a specialized quality control tool used in pharmaceutical and biotech manufacturing to make sure that products are free of visible defects. Essentially, Knapp Kits comprises of validated reference set of containers with known defects (e.g. vials or syringes containing intentional particulate matter, cracks, or cosmetic flaws). Quality control teams use these kits to train and qualify visual inspectors and to challenge automated inspection machines. By testing inspectors with known defective samples, manufacturers can verify that their inspection process will catch real-world defects before products reach patients.

Ensuring injectable (parenteral) products are essentially free of particulate matter is a critical requirement across all global regulatory agencies. Visible particles in IV fluids or injections can pose serious safety risks—causing emboli, infections, or immune reactions—and are a top cause of product recalls. Hence, 100% visual inspection of every parenteral unit is mandatory in pharmaceutical manufacturing. To meet this challenge, Nishka Research specializes in developing Visual Inspection Challenge Kits for parenteral products, providing innovative reference standards and training tools to help manufacturers comply with USP, FDA, EMA, WHO, PIC/S, PMDA and other global guidelines on particulate matter control.

Agglomeration in API

What is Knapp kit or visual inspection kit?

A Knapp kit or visual inspection kit is a calibrated and validated reference set of containers with known standard defects used for training, qualifying and verifying the performance of visual inspector and their inspection processes. These kits are particularly used in the pharmaceutical industry for parenteral and ophthalmic. These kits, which comply with USP <1790> guidelines, contain various types and sizes of particulates that simulate real-world contamination found in manufacturing.

Visible & Sub-Visible Particulates

Parenteral products can contain visible particles (generally >50–100 µm) that the human eye might detect, as well as sub-visible particles (≈2–50 µm) that require instrumentation to quantify. All regulatory pharmacopeias agree that injectable solutions must be “essentially free from any visible particles,” meaning no vial or syringe with observable particulate is acceptable. Sub-visible particulates are controlled via tests like USP 〈788〉 (light obscuration), but visual inspection remains the final safeguard for catching any macroscopic contaminants before products leave the factory. Common particulate contaminants include matter shed from contact parts—such as glass flakes from vials, rubber from stoppers, metal from equipment, or fibers from filters. These can be intrinsic particles (originating from the product or process) or extrinsic (foreign debris from the environment). Even inherent formulation particulates (e.g. protein aggregates or droplets in emulsions) must be distinguished so that only truly foreign particles cause rejection. Nishka’s visual inspection Challenge (Defective) kits help manufacturers address both visible and sub-visible particulate challenges by improving detection of visible particles and thereby reducing overall particulate load.

Nishka Research’s Visual Inspection Kits

Our Challenge (Reference Standards) kits are comprehensive defect reference standards designed for manual inspection training and qualification, with options to support semi-automated and fully automated inspection systems as well. Each kit contains a curated set of sample units (e.g. sealed vials or syringes) that intentionally include various defects and particulate contaminants alongside good units, emulating real-world scenarios. For example, particle-seeded samples may contain glass shards, stainless steel specks, rubber fragments, fibers or hair, spanning a range of sizes (commonly ~50 μm up to ~1000 μm). Cosmetic defects (like cracks, scratches, missing stoppers, or discoloration) are also incorporated to train inspectors to spot all critical flaws. Notably, Nishka can customize the kit to your product’s exact format: we prepare standards in the same containers and closure systems you use (glass vials, ampoules, pre-filled syringes, cartridges, etc.) so that trainees practice on a truly relevant system. Challenge Kits can even use your actual product or placebo solution as the fill media for authenticity, or we provide suitable surrogate solutions with proper refractive properties. This customization ensures training conditions closely mimic production, from liquid clarity to container size.

Global Regulatory Compliance

Nishka’s inspection Challenge kits are developed in alignment with international regulatory guidelines (USP <790>/<1790>, Ph. Eur. 2.9.20, JP 6.06, WHO GMP, etc.), helping you meet or exceed the expectations of US FDA, EU EMA, WHO, PIC/S, PMDA and other authorities. All these agencies require a robust visual inspection program: for instance, FDA and USP standards mandate that every injectable unit be visually examined and any container with visible particulates be rejected. Similarly, EU and PIC/S GMP guidelines insist on qualified inspectors and defect libraries to ensure no defective vial goes unnoticed. Nishka’s Challenge (Reference Standards) kits provide the “defect library” of reference particles and containers needed for initial inspector training, periodic re-qualification (at least annually), and even routine system challenges. By using our certified kits, manufacturers can demonstrate compliance with the “essentially free of particles” requirement in audits and regulatory filings. We supply full documentation (including certificates of analysis, traceability of seeded particles, and instructions) to support your QA approval of the test kits, as recommended by regulators.

Nishka Research is capable of developing customized Knapp Kits for your products

1. Small-Volume Parenterals (SVPs) – Glass Vials (Liquid Injections)
  • Detection of glass lamellae and flakes from vial inner surface
  • Recognition of elastomer fragments from stopper coring
  • Differentiation of air bubbles vs true particulates
  • Identification of stainless-steel slivers from filling needles
  • Assessment of cosmetic scratches vs critical cracks on vials
  • Visibility assessment of particles in clear vs coloured vehicles
2. Glass Ampoules (SVPs)
  • Identification of glass chips generated during tip-off
  • Detection of micro-cracks at the ampoule neck
  • Recognition of burnt or carbonized particles from flame sealing
  • Differentiation between cosmetic striations and structural defects
  • Visibility of foreign fibres in flame-sealed ampoules
3. Prefilled Syringes
  • Detection of silicone oil droplets
  • Identification of plunger-related elastomer particulates
  • Recognition of tungsten residues from needle forming
  • Differentiation of cosmetic barrel marks vs cracks
  • Visibility assessment in narrow optical path containers
4. Blow-Fill-Seal (BFS) Ampoules / Bottles
  • Detection of polymer gels and molten resin particulates
  • Recognition of burn particles from improper extrusion conditions
  • Identification of weld-zone cosmetic anomalies
  • Differentiation of process-induced inclusions vs foreign particles
  • Visibility assessment in polymer containers with variable wall thickness
5. Protein & Biologic Injectables
  • Differentiation of protein aggregates vs foreign particulates
  • Recognition of reversible vs irreversible aggregation
  • Assessment of opalescence vs particulate contamination
  • Visibility of sub-visible aggregates at the visual threshold
  • Differentiation of inherent formulation haze vs contamination
6. Ophthalmic Preparations
  • Detection of fine fibres in clear ophthalmic solutions
  • Recognition of container-closure interaction debris
  • Differentiation of air micro-bubbles vs particulate matter
  • Identification of mould-release residues in plastic containers
  • Visibility assessment under low-contrast conditions
7. Nasal Sprays & Inhalation Liquids
  • Detection of foreign fibres in viscous formulations
  • Recognition of actuator or pump-related particulates
  • Differentiation of formulation droplets vs solid particles
  • Identification of plastic debris from pump components
8. Large-Volume Parenterals (IV Bags – 50 mL, 100 mL, LVP)
  • Detection of fibres within large optical field containers
  • Identification of gel-like particulates
  • Recognition of film inclusions within bag material
  • Assessment of weld seam cosmetic defects
  • Differentiation of container film defects vs internal particulates

Key Features and Benefits

  • Comprehensive Training: Provides a controlled set of known defects for training personnel to reliably detect visible particles and differentiate good vs. bad units. This builds inspector acuity and confidence, reducing human error during 100% manual inspection.
  • Qualification & Requalification: Serves as formal qualification test sets for manual inspectors, semi-automated inspection stations (SAVI), and automated inspection machines (AVI). Our Challenge (Defective) kits support initial qualification and ongoing requalification per GMP – ensuring your team (or machine vision system) maintains proven detection capability over time.
  • Regulatory Alignment: Challenge (Defective) Kits are designed according to USP <1790> guidance and FDA/PIC/S recommendations for defect set composition (e.g. ~10–20% defect rate in kits, with mix of particle and cosmetic defects). Using these Challenge kits helps fulfill regulatory expectations for a risk-based visual inspection program, including documentation for inspections and audits.
  • Customized for Your Products: We tailor each kit to reflect the product-specific conditions. Whether you produce clear liquid injectables, lyophilized (freeze-dried) powders, or emulsions, Nishka can develop appropriate test units. For clear liquids, we provide particles of appropriate visibility in solution. For lyophilized products, we offer mock lyophilized vials with embedded foreign particles (plus guidance on inspecting reconstituted samples for sub-visible matter). For opaque or emulsion products, we advise on supplementary methods (e.g. light obscuration, X-ray imaging) to augment visual inspection, in line with FDA recommendations. In all cases, our Challenge kits enhance your ability to detect contaminants despite product or container challenges.
  • Improved Particulate Control: By training with our kits, manufacturers typically see improved detection rates of visible contaminants, leading to fewer batch rejections or customer complaints due to particles. A well-trained inspectorate and calibrated automated procedures serve as a timely caution system for process issues (e.g. shedding equipment or component defects), allowing proactive corrective actions. Overall, this supports a holistic particulate control program as urged by regulators.

Frequently Asked Questions

What exactly is a Knapp Kit?
K
L
A Knapp Kit is a validated set of containers seeded with known, pre-characterized defects, used to train, qualify and periodically re-qualify visual inspectors. It helps demonstrate that inspectors (or machines) can reliably detect real-world defects under routine inspection conditions.
Are Knapp Kits mandatory under regulations?
K
L
Knapp Kits are not named explicitly as “mandatory,” but their use is strongly implied. Regulations require proven inspector qualification and performance verification. Knapp Kits are the most widely accepted practical method to meet that expectation during audits.
What types of defects are typically included in a Knapp Kit?
K
L
Common defects include glass particles, metal fragments, fibers (polyester, cellulose, PTFE), rubber or silicone particles, plastic flakes, cracks, scratches and cosmetic container defects. The exact mix should reflect real risks from your process and packaging.
What is the minimum particle size used in Knapp Kits?
K
L
In practice, Knapp Kits focus on particles around and above the reliable visual detection threshold, typically ≥100 µm. Smaller particles may be included for awareness, but qualification decisions are based on sizes inspectors can realistically detect.
Why aren’t very small particles (e.g., 50 µm) emphasized?
K
L
Because visual inspection is probabilistic. Below ~100 µm, detection becomes inconsistent even under ideal conditions. Regulators expect science-based justification, not unrealistic expectations of human vision.
How often should inspectors be qualified using Knapp Kits?
K
L
Initial qualification is followed by periodic re-qualification, commonly annually and additionally after extended absence, poor performance, or major process changes. Frequency should be risk-based and justified in SOPs.
Can the same Knapp Kit be used for all products?
K
L
No. One of the most common audit gaps is using a “generic” kit for dissimilar products. Kits should be aligned to container type, product clarity, viscosity and known defect mechanisms.
Are Knapp Kits used only for manual inspection?
K
L
No. Knapp Kits are used for both manual and automated visual inspection systems. For automated systems, they help validate camera sensitivity, lighting configuration and defect recognition logic.
How are Knapp Kits used in automated inspection qualification?
K
L

They are run during FAT, SAT and PQ to demonstrate that the system detects representative defects with acceptable detection probability and false-reject rates, comparable to or better than manual inspection.

Do Knapp Kits expire?
K
L
Yes. Defect stability can change over time. Most organizations assign a defined validity period (often 18–24 months), after which the kit is reviewed, re-certified, or replaced.
Can real rejected production units be used instead of Knapp Kits?
K
L

They can be part of a defect library, but relying only on random rejects is risky. Knapp Kits provide controlled, repeatable and documented challenges, which regulators prefer over ad-hoc samples.

How many defect units should be present in a Knapp Kit?
K
L

Typically, only a small percentage of the kit contains defects (often around 10–20%). Overloading a kit with defects can bias inspectors and does not reflect real inspection conditions.

Are Knapp Kits applicable to BFS containers?
K
L

Yes. BFS formats have unique challenges such as wall cling, optical distortion and low fill volumes. Customized Knapp Kits are commonly used for BFS ampoules, bottles and ophthalmic BFS packs.

How do Knapp Kits differ for biologics?
K
L

Biologic kits often include simulated aggregates, silicone-related particles, rubber fragments and temperature-sensitive defects, reflecting risks unique to protein formulations.

Can Knapp Kits help reduce false rejects?
K
L

Yes. Properly designed kits train inspectors to differentiate true defects from acceptable artifacts (air bubbles, meniscus effects, silicone droplets), which improves consistency and reduces unnecessary rejects.

What documentation should accompany a Knapp Kit?
K
L
A complete kit should include defect descriptions, Images of defects added, particle size/type information, container details, usage instructions, validity period and traceability records suitable for audit review.
Who should approve Knapp Kits internally?
K
L

Quality Assurance should formally review and approve the kit design, usage SOPs, qualification criteria and re-certification approach.

Can Knapp Kits be customized for multiple markets?
K
L

Yes. Many companies design kits to satisfy global expectations simultaneously, aligning with US, EU, Japan, WHO and other regulatory philosophies in one coherent strategy.

What is a common mistake companies make with Knapp Kits?
K
L

Using the same kit for years without review, or using a visually impressive but scientifically unjustified kit. Regulators look for relevance, not just presence.

How do Knapp Kits support audit readiness?
K
L

They provide tangible evidence that inspection performance is trained, tested, monitored and maintained in a controlled and repeatable manner—something auditors consistently expect but rarely see done well.

Are Nishka Research Knapp Kits regulator-ready?
K
L

Yes. Nishka Research is the industry leader for customized Knapp Kits which are developed with direct alignment to USP, FDA, EMA, WHO, PMDA and CDSCO expectations, including inspector qualification, PoD logic and audit documentation.

Who manufactures certified Knapp Kits globally?
K
L

Nishka Research is the reputed global manufacturer and supplier of certified, application-specific Knapp Kits, designed to meet USP <790>/<1790> and global regulatory expectations across injectables, BFS, biologics and ophthalmics.

What makes Nishka Research Knapp Kits different?
K
L

Nishka Research designs science-driven, risk-based Knapp Kits, not generic training samples. Each kit is customized to product, packaging and inspection method, with documented defect logic suitable for regulatory audits worldwide.

Why is Nishka Research considered a pioneer in Knapp Kits?
K
L
Because Nishka Research combines regulatory understanding, defect science and real manufacturing data to design Knapp Kits that go beyond compliance and actively improve inspection reliability. They do site audit if necessary, so as to customize design the Knapp kits.
Does Nishka Research supply Knapp Kits globally?
K
L

Yes. Nishka Research supports global pharmaceutical and biotech manufacturers, exporters and inspection teams across regulated markets with certified Knapp Kits and documentation.

Can Knapp Kits be aligned to multiple global regulators in one design?
K
L

Yes. Nishka Research routinely designs globally harmonized Knapp Kits, satisfying US, EU, Japan, WHO and emerging-market expectations in a single strategy.

Are Knapp Kits used for automated inspection systems?
K
L

Yes. Nishka Research supplies AVI-specific Knapp Kits used during FAT, SAT, PQ and periodic re-qualification to validate camera sensitivity and detection logic.

How do Knapp Kits support automated inspection validation?
K
L

They provide known, traceable defects that allow objective verification of detection probability, false-reject rates and equivalence to manual inspection, as expected by global regulators.

What does a typical Visual Inspection Kit include?
K
L

It typically includes a few hundred containers (500–600 vials, ampoules, or syringes). Around 10–20% of units (50–100) are defective samples with predefined flaws. These defects may include particles (glass, metal, fibers), cracks or other visible abnormalities.

Do we need separate Visual Inspection Kits for different products or container types?
K
L
Separate Visual Inspection Kits are recommended for each product or container type, since packaging and formulation differences create unique inspection challenges
How can Nishka Research assist with customized Knapp Kits and compliance?
K
L
Nishka Research specializes in developing and implementing Customized Knapp Kits for parenteral, Ophthalmic and Biological products. We design custom defect kits tailored to each product, covering relevant particles and container defects.
What is the Knapp test protocol?
K
L

The Knapp Test is one of the protocols approved by international regulations to assess the effectiveness of an instrument in performing visual inspections. In this type of test, a set of samples is inspected by both qualified human operators and the machine

Why ChooseNishka Research

Nishka Research is committed to advancing patient safety and product quality through innovative visual inspection solutions. Our Visual Inspection Challenge Kits for parenteral products empower pharmaceutical manufacturers to achieve the highest standards of particulate cleanliness, ensuring that every injectable dose delivered is free from harmful visible matter. By partnering with Nishka Research, you gain not only a set of defect standards, but a complete support system for training, qualification, and continuous improvement in your visual inspection process – a critical component of sterile product GMP compliance worldwide.

Looking for a trusted partner to achieve your research goals? schedule a meeting with us, send us a request, or call us at +91 78427 98518 to learn more about our services and how we can support you.

Need help or have a question?

+91 78427 98518

Nishka Research Brochure

We deliver next-gen research services, Testing & Consultation know more..

Ch. Rohan

Ch. Rohan

Typically replies within an hour

I will be back soon

Ch. Rohan
Hello 👋 Thanks for your interest in us. Before we begin, may I know your name?
Start Chat with:
chat Need Help?